OptimizeRx
OPRX
OPRX
128 hedge funds and large institutions have $228M invested in OptimizeRx in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 54 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
128
Holders Change
+1
Holders Change %
+0.79%
% of All Funds
2.07%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
22
Increased
34
Reduced
54
Closed
18
Calls
$16.1M
Puts
$380K
Net Calls
+$15.7M
Net Calls Change
+$2.5M
Top Buyers
| 1 |
GIPM
G2 Investment Partners Management
New York
|
$12.3M |
| 2 |
CC
Casdin Capital
New York
|
$4.37M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
$3.11M |
| 4 |
JPMorgan Chase & Co
New York
|
$2.4M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$3.94M |
Top Sellers
| 1 |
Handelsbanken Fonder
Stockholm,
Sweden
|
$3.87M |
| 2 |
Millennium Management
New York
|
$921K |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
$4.62M |
| 4 |
Two Sigma Advisers
New York
|
$3.31M |
| 5 |
Two Sigma Investments
New York
|
$2.13M |
